Topiramate
NDC 10370-365, Topiramate, capsule, extended release, from Par Health USA, LLC.
- Product NDC
- 10370-365
- Status
- Listed
- Labeler
- Par Health USA, LLC
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205976
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10370-365 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOPIRAMATE25 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10370-365-01 | 10370036501 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-365-01) |
| 10370-365-11 | 10370036511 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-365-11) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/11e0924b-fbee-4ec4-b1e4-22d7683b21eeNADAC price for package 10370036501
GET /v1/drugs/nadac/10370036501NADAC price for package 10370036511
GET /v1/drugs/nadac/10370036511
Use it
Look up 10370-365 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10370-365 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10370-365. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.